XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.86 / 10Overall Score
NeturalInvestment Rating
4.86 / 10Overall Score
NeturalInvestment Rating
Is XENE a Good Buy Right Now?
- Based on a composite score of 4.86/10, we rate XENE as a Netural. Our analysis breaks down into 4.89/10 for Fundamentals, 4.71/10 for Technicals, and 4.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of XENE?
Is XENE undervalued or overvalued?
Is money flowing into or out of XENE?
Is XENE a Good Buy Right Now?
- Based on a composite score of 4.86/10, we rate XENE as a Netural. Our analysis breaks down into 4.89/10 for Fundamentals, 4.71/10 for Technicals, and 4.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is XENE undervalued or overvalued?
Technical Analysis of XENE?
Is money flowing into or out of XENE?
